Eiger BioPharmaceuticals logo
Eiger BioPharmaceuticals EIGR
report update icon

Quarterly report 2023-Q3
added 05-16-2026

Eiger BioPharmaceuticals Cash Conversion Cycle | EIGR

Annual Cash Conversion Cycle Eiger BioPharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-50.8 K -1.06 K -2.34 K - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.06 K -50.8 K -18.1 K

Quarterly Cash Conversion Cycle Eiger BioPharmaceuticals

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-2.94 K 74.7 -4.89 K - -257 -2.18 K -5.09 K - -871 -1.43 K -9.37 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
74.7 -9.37 K -3 K

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer Cash Conversion Cycle Price % 24h Market Cap Country
AbbVie AbbVie
ABBV
284 $ 263.04 0.49 % $ 465 B usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
173 $ 11.41 2.15 % $ 3.41 B canadaCanada
Фармсинтез Фармсинтез
LIFE
-15.9 - - - russiaRussia
Aclaris Therapeutics Aclaris Therapeutics
ACRS
-1.55 K $ 5.53 6.02 % $ 678 M usaUSA
ADC Therapeutics SA ADC Therapeutics SA
ADCT
-543 $ 1.09 3.74 % $ 139 M schweizSchweiz
Clovis Oncology Clovis Oncology
CLVS
271 - -7.23 % $ 13 M usaUSA
Chimerix Chimerix
CMRX
52.5 - - $ 756 M usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
5.06 - - $ 401 M usaUSA
ADMA Biologics ADMA Biologics
ADMA
355 $ 8.61 0.16 % $ 2.05 B usaUSA
Fusion Pharmaceuticals Fusion Pharmaceuticals
FUSN
6 - - $ 1.41 B canadaCanada
Guardion Health Sciences Guardion Health Sciences
GHSI
160 - -0.31 % $ 3.64 M usaUSA
Genocea Biosciences Genocea Biosciences
GNCA
24.9 - -15.0 % $ 3.04 M usaUSA
Gritstone Oncology Gritstone Oncology
GRTS
40.3 - 0.42 % $ 213 M usaUSA
G1 Therapeutics G1 Therapeutics
GTHX
52.6 - - $ 370 M usaUSA
Humanigen Humanigen
HGEN
598 - -81.12 % $ 4.28 M usaUSA
HOOKIPA Pharma HOOKIPA Pharma
HOOK
3.33 - -6.92 % $ 79.4 M usaUSA
Intercept Pharmaceuticals Intercept Pharmaceuticals
ICPT
-3.11 K - - $ 643 M usaUSA
Intra-Cellular Therapies Intra-Cellular Therapies
ITCI
257 - - $ 13.6 B usaUSA
Chinook Therapeutics Chinook Therapeutics
KDNY
0.93 - - $ 2.6 B usaUSA
Karuna Therapeutics Karuna Therapeutics
KRTX
15.9 - - $ 12.2 B usaUSA
La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company
LJPC
34.8 - - $ 154 M usaUSA
LogicBio Therapeutics LogicBio Therapeutics
LOGC
9.88 - - $ 229 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
13.7 - - $ 35.3 M usaUSA
Merrimack Pharmaceuticals Merrimack Pharmaceuticals
MACK
645 - - $ 216 M usaUSA
Mirati Therapeutics Mirati Therapeutics
MRTX
12.7 - - $ 3.3 B usaUSA
9 Meters Biopharma 9 Meters Biopharma
NMTR
27.9 - -42.97 % $ 1.05 M usaUSA
Nymox Pharmaceutical Corporation Nymox Pharmaceutical Corporation
NYMX
-2.39 K - -19.68 % $ 18.4 M canadaCanada
Oncternal Therapeutics Oncternal Therapeutics
ONCT
-345 - -24.12 % $ 1.56 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
84.9 - - $ 109 M usaUSA
Orchard Therapeutics plc Orchard Therapeutics plc
ORTX
-295 - 1.02 % $ 90.8 M britainBritain